Condensed Consolidated Statement of Loss of Immatics N.V. - EUR (€) € in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Profit or loss [abstract] | ||||
| Revenue from collaboration agreements | € 9,144 | € 4,737 | € 16,756 | € 23,318 |
| Research and development expenses | (62,411) | (45,106) | (121,597) | (87,014) |
| General and administrative expenses | (13,937) | (12,780) | (28,450) | (24,847) |
| Other income | 22 | 24 | 41 | |
| Operating result | (67,204) | (53,127) | (133,267) | (88,502) |
| Change in fair value of liabilities for warrants | 0 | 133 | 0 | 1,730 |
| Other financial income | 4,802 | 4,421 | 13,341 | 10,685 |
| Other financial expenses | (364) | (22,776) | (602) | (36,113) |
| Financial result | 4,438 | (18,222) | 12,739 | (23,698) |
| Loss before taxes | (62,766) | (71,349) | (120,528) | (112,200) |
| Taxes on income | 274 | 1,001 | 222 | 1,996 |
| Net profit/(loss) | € (62,492) | € (70,348) | € (120,306) | € (110,204) |
| Net loss per share: | ||||
| Basic | € (0.46) | € (0.58) | € (0.89) | € (0.91) |
| Diluted | € (0.46) | € (0.58) | € (0.89) | € (0.91) |
| X | ||||||||||
- Definition The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The gains (losses) on financial liabilities at fair value through profit or loss. [Refer: Financial liabilities at fair value through profit or loss] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Revenue from collaboration agreements No definition available.
|